Archive · 26 Dec 2025
Gujarat Kidney IPO Sees Strong Demand
Gujarat Kidney & Super Speciality, a healthcare company, recently had its IPO.
The IPO was very popular and got subscribed 5.21 times, especially by regular and small investors.
The company plans to use the money raised to buy hospitals, get new equipment, and pay off some debts.
The shares are expected to start trading on December 29, 2025.
Investors can check if they got shares on the BSE, NSE, or through the IPO registrar.
The company runs several hospitals and pharmacies in Gujarat and has been growing its profits and revenue.
Gujarat Kidney's IPO was subscribed 5.21 times, with strong demand from retail and NII investors.
The grey market premium (GMP) is ₹0, suggesting the stock may debut at the IPO price of ₹114.
The ₹250.80 crore IPO is entirely a fresh issuance of 2.20 crore shares.
Proceeds will be used for acquiring hospitals, capital expenditure, and general corporate purposes.
The company operates 7 multispeciality hospitals and 4 pharmacies, with a total of 490 beds.
- Who
- Gujarat Kidney & Super Speciality
- What
- IPO subscription and allotment
- When
- December 22-24, 2025 (subscription), December 26, 2025 (allotment), December 29, 2025 (listing)
- Where
- BSE and NSE
- Why
- To raise funds for acquisitions, capital expenditure, and general corporate purposes
Investor Sentiment
Market Performance
Grey Market Premium
Investor Sentiment
The grey market premium (GMP) for Gujarat Kidney's IPO is ₹0, indicating muted investor sentiment and suggesting the stock may debut at the IPO price of ₹114.
Market Performance
Despite the muted GMP, the IPO was subscribed 5.21 times, showing strong demand, particularly from retail and NII investors.
- IPO Subscription
- 5.21 times
- Retail Subscription
- 19.04 times
- NII Subscription
- 5.73 times
- QIB Subscription
- 1.06 times
- IPO Size
- ₹250.80 crore
- Price Band
- ₹108-₹114 per share
- Allotment Date
- December 26, 2025
- Listing Date
- December 29, 2025
- Anchor Investors
- Over ₹100 crore raised
- Lead Manager
- Nirbhay Capital Services
- Registrar
- MUFG Intime India Pvt. Ltd
- Hospitals Operated
- 7 multispeciality hospitals and 4 pharmacies
- Beds Available
- 490 beds
- Net Profit FY25
- ₹9.49 crore
- Revenue FY25
- ₹40.24 crore
Sources
Last day to buy Gujarat Kidney IPO: Check GMP, subscription status, IPO review - Apply or not?
Gujarat Kidney IPO Day 3 LIVE: Last day to apply for IPO — Check latest GMP, review and other details
Global Ocean Logistics IPO listing: Shares list at 1.5% premium over IPO price, extend gains
Gujarat Kidney & Super Speciality AMC IPO subscription: Check day 3 bidding & latest GMP
Gujarat Kidney and Super Speciality IPO subscribed 4.62 times so far on final day
Gujarat Kidney IPO booked 5.2x on final day; retail investors show strong interest, GMP indicates muted listing
Gujarat Kidney IPO Subscribed 5.2x On Last Day
